Answers are grounded in this paper and cite their sources.
Multiple sclerosis (MS) is a chronic demyelinating disease of the CNS estimated to reduce life expectancy by 7–14 years compared to demographically similar groups in the general population.1 While several disease complications pose a potential risk for mortality, results from large observational studies suggest that comorbidities substantially influence survival in MS.2,3
No takes yet. Share an insight, caveat, or question.
Karamyan et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: